The price-to-earning (P/E) ratios of a few pharmaceutical stocks are currently higher than the industry average of 12.21, indicating expectations of good results from these companies.
For instance, Astra Zeneca
The price-to-earning (P/E) ratios of a few pharmaceutical stocks are currently higher than the industry average of 12.21, indicating expectations of good results from these companies.
For instance, Astra Zeneca
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 30 2002 | 12:00 AM IST